🕵️ Cognition Therapeutics Inc ($CGTX)
SEC insider & ownership activity, last 12 months · CIK 1455365 · every row links its SEC filing
Over the last 12 months insiders bought $32K with no open-market selling against it. Doyle John Brendan bought $11K in discretionary trades (Apr). No red-flag 8-Ks in the window.
Monthly net open-market insider flow, last 12 months (up = net buying)
Insider flow
3 buyers, $32K (3 lots) · 0 sellers, $0 (0 lots)
| Insider | Buys | Bought | Sells | Sold | Last |
|---|---|---|---|---|---|
| Doyle John Brendan | 1 | $11K | 0 | – | Apr 16, 2026 |
| Caggiano Anthony | 1 | $11K | 0 | – | Apr 16, 2026 |
| Ricciardi Lisa | 1 | $10K | 0 | – | Apr 16, 2026 |
5%+ holders
| Holder | Stake | Class | Schedule | Event | |
|---|---|---|---|---|---|
| Aaron G.l. Fletcher | 6.9% | 13D | Sep 19, 2025 | filing ↗ | |
| BIOS Advisors GP, LLC | 6.8% | 13D | Sep 19, 2025 | filing ↗ | |
| BIOS Capital Management, LP | 6.8% | 13D | Sep 19, 2025 | filing ↗ | |
| CAVU Management, LP | 6.3% | 13D | Sep 19, 2025 | filing ↗ | |
| CAVU Advisors, LLC | 6.3% | 13D | Sep 19, 2025 | filing ↗ | |
| Leslie W. Kreis | 6.3% | 13D | Sep 19, 2025 | filing ↗ |
Planned insider sales (Form 144)
No sale notices filed in the last 12 months.
Material events (8-K)
| Item | Event date | |
|---|---|---|
| Other events (8.01) | Jun 24, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 24, 2026 | filing ↗ |
| Shareholder vote (5.07) | Jun 17, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Jun 4, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jun 4, 2026 | filing ↗ |
| Other events (8.01) | May 21, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 21, 2026 | filing ↗ |
| Earnings (2.02) | May 7, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | May 7, 2026 | filing ↗ |
| Earnings (2.02) | Mar 26, 2026 | filing ↗ |
| Reg FD disclosure (7.01) | Mar 26, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 26, 2026 | filing ↗ |
| Other events (8.01) | Mar 2, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Mar 2, 2026 | filing ↗ |
| Other events (8.01) | Jan 27, 2026 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Jan 27, 2026 | filing ↗ |
| Material agreement (1.01) | Dec 16, 2025 | filing ↗ |
| Agreement terminated (1.02) | Dec 16, 2025 | filing ↗ |
| Earnings (2.02) | Nov 6, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Nov 6, 2025 | filing ↗ |
| Other events (8.01) | Sep 15, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Sep 15, 2025 | filing ↗ |
| Material agreement (1.01) | Aug 27, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 27, 2025 | filing ↗ |
| Other events (8.01) | Aug 26, 2025 | filing ↗ |
| Earnings (2.02) | Aug 7, 2025 | filing ↗ |
| Financial Statements and Exhibits (9.01) | Aug 7, 2025 | filing ↗ |